期刊文献+

心肌特异性脂肪酸结合蛋白在不停跳冠状动脉搭桥术中的变化

Perioperative changes of hFABP in patients undergoing off-pump coronary artery bypass grafting
原文传递
导出
摘要 Objective To appraise the sensitivity of hFABP for myocardial ischemia in patients undergoing off-pump coronary artery bypass grafting among cardiac markers. Methods Thirty-eight consecutive patients undergoing OPCABG were included in a randomized study using standardized operative procedures and myocardial protection. Serial blood samples were taken preoperatively, during anastomoses, at the end of operation, 6 h, 18 h and 36 h postoperatively and tested for hFABP、Troponin I (cTnI)、sCD40L、creatine kinase isoenzyme (CK-MB). Results Six cases (16.7%) were found myocardial injury during the OPCABG by ECG or PAP. Their serial serum hFABP,cTnI,sCD40L,CK-MB were higher than those without myocardial injury. The peak serum level of hFABP was higher and occurred earlier than those of cTnI,sCD40L,CK-MB. Conclusion These results suggest that serum hFABP is an early and sensitive biochemical marker for the diagnosis of myocardial injury in patients undergoing OPCABG. Objective To appraise the sensitivity of hFABP for myocardial ischemia in patients undergoing off-pump coronary artery bypass grafting among cardiac markers. Methods Thirty-eight consecutive patients undergoing OPCABG were included in a randomized study using standardized operative procedures and myocardial protection. Serial blood samples were taken preoperatively, during anastomoses, at the end of operation, 6 h, 18 h and 36 h postoperatively and tested for hFABF,Troponin Ⅰ (cTnⅠ) ,sCD40L,creatine kinase isoenzyme (CK-MB). Results Six cases (16.7%) were found myocardial injury during the OPCABG by ECG or PAP. Their serial serum hFABP,cTnⅠ,sCD40L, CK-MB were higher than those without myocardial injury. The peak serum level of hFABP was higher and occurred earlier than those of cTnⅠ, sCD40L,CK-MB. Conclusion These results suggest that serum hFABP is an early and sensitive biochemical marker for the diagnosis of myocardial injury in patients undergoing OPCABG.
出处 《国际麻醉学与复苏杂志》 CAS 2006年第3期158-160,共3页 International Journal of Anesthesiology and Resuscitation
基金 江苏省医学重点学科徐州医学院附属医院(麻醉学)资助(项目编号WK200203)
关键词 heart-type fatty acid binding protein myocardial ischemia coronary artery bypass grafting target-controlled infusion heart-type fatty acid binding protein myocardial ischemia coronary artery bypass grafting target-controlled infusion
  • 相关文献

参考文献10

  • 1Ghani F, Wu AHB, Graft LC, et al. Role of heart-type fatty acld-binding protein in early detection of acute myocardial infarction. Clin chem, 2000,46(5) : 718-719.
  • 2Myles PS, Hunt JO, Fletcher H, et al. Remifentanil, fentanyl, and cardiac surgery: A double-blinded, randomized, controlled trial of costs and outcomes. Anesth Analg, 2002, 95(4) :805-812.
  • 3Glatz JFC, Storch J. Unravelling the significance of cellular fatty acidbinding proteins. Curt Opinion Lipidol, 2001,12:267-274.
  • 4Van der Vusse GJ, Glatz JFC, Stam HCG, et al. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev, 1992,72:881-940.
  • 5Bonatti J, hangler H, Hormann C, et al. Myocardial damage after minimally invasive coronary bypass grafting on the beating heart. Ann Thorac Surg,1998, 66(3) : 1093-1096.
  • 6Hendrikx M, Jiang H, Gutermann H, et al. Release of cardiac troponin I in antegrade crystalloid versus cold blood cardioplegia. J Thorac Cardiovasc Surg, 1999,118(3) : 452-459.
  • 7Urbich C, Dembaeh E, Aicher A, et al. CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation, 2002,106(8): 981-986.
  • 8Heeschen C, Dimmeler S, Harem CW, et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med, 2003,348: 1104-1111.
  • 9Kinlay S, Schwartz GG, Olsson AG,et al. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the myocardial iachemia reduction with aggressive cholesterol lowering (MIRACL) study. Circulation, 2004,110:386-391.
  • 10Petzold T, Feindt P, Sunderdiek U, et al. Heart-type fatty binding protein in the diagnosis of myocardial damage in coronary artery bypass grafting. Eur J Cardiothorac Surg, 2001,19(6) :859-864.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部